Outcomes associated with a five-point surgical site infection prevention bundle in women undergoing surgery for ovarian cancer

Obstetrics and Gynecology

Volumn 130, Issue 4, 2017, Pages 756-764

  Lippitt, Melissa H ^a   Fairbairn, Melissa Gerardi ^a   Matsuno, Rayna ^a   Stone, Rebecca L ^a   Tanner, Edward J ^a   Wick, Elizabeth C ^a   Angarita, Ana C ^a   Roche, Kara Long ^a   Levinson, Kimberly L ^a   Bergstrom, Jennifer E ^a   Sinno, Abdulrahman K ^a   Curless, Melanie S ^a   Wethington, Stephanie ^a   Temkin, Sarah M ^a   Efron, Jonathan ^a   Hobson, Deborah ^a   Fader, Amanda N ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CHLORHEXIDINE; ANTIINFECTIVE AGENT; TOPICAL ANTIINFECTIVE AGENT;

ABDOMINAL SURGERY; ADULT; BLEEDING; COLON RESECTION; COMORBIDITY; CONFERENCE PAPER; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; FALLOPIAN TUBE; FEMALE; HOSPITAL READMISSION; HUMAN; INFECTION PREVENTION; INFECTION RATE; INFECTION RISK; INTESTINE PREPARATION; MAJOR CLINICAL STUDY; MIDDLE AGED; OUTCOME ASSESSMENT; OVARY CANCER; PERITONEUM CANCER; PRIORITY JOURNAL; PROSPECTIVE STUDY; SURGICAL INFECTION; TERTIARY CARE CENTER; ABDOMEN; ADVERSE EFFECTS; ANTIBIOTIC PROPHYLAXIS; CARE BUNDLE; COLON; EVALUATION STUDY; FALLOPIAN TUBE NEOPLASMS; ODDS RATIO; OVARIAN NEOPLASMS; PERITONEAL NEOPLASMS; PROCEDURES; STANDARDS; SURGICAL WOUND INFECTION; TOTAL QUALITY MANAGEMENT; TREATMENT OUTCOME;

ABDOMEN; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS, LOCAL; ANTIBIOTIC PROPHYLAXIS; CHLORHEXIDINE; COLON; CYTOREDUCTION SURGICAL PROCEDURES; FALLOPIAN TUBE NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; ODDS RATIO; OVARIAN NEOPLASMS; PATIENT CARE BUNDLES; PATIENT READMISSION; PERITONEAL NEOPLASMS; PROSPECTIVE STUDIES; QUALITY IMPROVEMENT; SURGICAL WOUND INFECTION; TREATMENT OUTCOME;

EID: 85030616181     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/AOG.0000000000002213     Document Type: Conference Paper

References (46)

1. Mangano DT. Perioperative medicine: NHLBI working group deliberations and recommendations. J Cardiothorac Vasc Anesth 2004; 18: 1-6.
2. Sauerland S, Jaschinski T, Neugebauer EA. Laparoscopic versus open surgery for suspected appendicitis. The Cochrane Database of Systematic Reviews 2010, Issue 10. Art. No.: CD001546. doi: 10.1002/14651858.CD001546.pub3.
3. Schwenk W, Haase O, Neudecker J, Müller J. Short term benefits for laparoscopic colorectal resection. The Cochrane Database of Systematic Reviews 2005, Issue 3. Art. No.: CD003145. doi: 10.1002/14651858.CD003145.pub2.
4. Aimaq R, Akopian G, Kaufman HS. Surgical site infection rates in laparoscopic versus open colorectal surgery. Am Surg 2011; 77: 1290-4.
5. Kiran RP, El-Gazzaz GH, Vogel JD, Remzi FH. Laparoscopic approach significantly reduces surgical site infections after colorectal surgery: data from National Surgical Quality Improvement Program. J Am Coll Surg 2010; 211: 232-8.
6. Fader AN, Weise RM, Sinno AK, Tanner EJ III, Borah BJ, Moriarty JP, et al. Utilization of Minimally Invasive surgery in endometrial cancer care. Obstet Gynecol 2016; 127: 91-100.
7. Centers for Disease Control and Prevention. 2014 national and state healthcare-Associated infections progress report. Available at: www.cdc.gov/hai/progress-report/index.html. Retrieved March 2016.
8. Szender JB, Frederick PJ, Eng KH, Akers SN, Lele SB, Odunsi K. Evaluation of the National Surgical Quality Improvement Program universal surgical risk calculator for a gynecologic oncology service. Int J Gynecol Cancer 2015; 25: 512-20.
9. Mahdi H, Gojayev A, Buechel M, Knight J, SanMarco J, Lockhart D, et al. Surgical site infection in women undergoing surgery for gynecologic cancer. Int J Gynecol Cancer 2014; 24: 779-86.
10. Uçkay I, Harbarth S, Peter R, Lew D, Hoffmeyer P, Pittet D. Preventing surgical site infections. Expert Rev Anti Infect Ther 2010; 8: 657-70.
11. Gerestein CG, Damhuis RA, de Vries M, Reedijk A, Burger CW, Kooi GS. Causes of postoperative mortality after surgery for ovarian cancer. Eur J Cancer 2009; 45: 2799-803.
12. Matsuo K, Prather CP, Ahn EH, Eno ML, Tierney K, Yessaian AA, et al. Significance of perioperative infection in survival of patients with ovarian cancer. Int J Gynecol Cancer 2012; 22: 245-53.
13. Wick EC, Hobson DB, Bennett JL, Demski R, Maragakis L, Gearhart S, et al. Implementation of a surgical comprehensive unit-based safety program to reduce surgical site infections. J Am Coll Surg 2012; 215: 193-200.
14. Saeed MJ, Dubberke ER, Fraser VJ, Olsen MA. Procedurespecific surgical site infection incidence varies widely within certain National Healthcare Safety Network surgery groups. Am J Infect Control 2015; 43: 617-23.
15. Chang SJ, Bristow RE, Chi DS, Cliby WA. Role of aggressive surgical cytoreduction in advanced ovarian cancer. J Gynecol Oncol 2015; 26: 336-42.
16. Tran CW, McGree ME, Weaver AL, Martin JR, Lemens MA, Cliby WA, et al. Surgical site infection after primary surgery for epithelial ovarian cancer: predictors and impact on survival. Gynecol Oncol 2015; 136: 278-84.
17. Bristow RE, Zahurak ML, Diaz-Montes TP, Giuntoli RL, Armstrong DK. Impact of surgeon and hospital ovarian cancer surgical case volume on in-hospital mortality and related short-Term outcomes. Gynecol Oncol 2009; 115: 334-8.
18. Damle RN, Macomber CW, Flahive JM, Davids JS, Sweeney WB, Sturrock PR, et al. Surgeon volume and elective resection for colon cancer: an analysis of outcomes and use of laparoscopy. J Am Coll Surg 2014; 218: 1223-30.
19. Deierhoi RJ, Dawes LG, Vick C, Itani KM, Hawn MT. Choice of intravenous antibiotic prophylaxis for colorectal surgery does matter. J Am Coll Surg 2013; 217: 763-9.
20. Center for Disease Control. 2016 National Healthcare Safety Network (NHSN) patient safety component manual. Available at: https://www.cdc.gov/nhsn/pdfs/validation/2016/pcsmanual-2016.pdf. Retrieved March 21, 2017.
21. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982; 5: 649-55.
22. American Society of Anesthesiologists. ASA physical status classification system. Available at: https://www.asahq.org/resources/clinical-information/asa-physical-status-classificationsystem. Retrieved March 21, 2017.
23. Edmiston CE Jr, Bruden B, Rucinski MC, Henen C, Graham MB, Lewis BL. Reducing the risk of surgical site infections: does chlorhexidine gluconate provide a risk reduction benefit? Am J Infect Control 2013; 41(suppl): S49-55.
24. Al-Niaimi A, Rice LW, Shitanshu U, Garvens B, Fitzgerald M, Zerbel S. Safety and tolerability of chlorhexidine gluconate (2%) as a vaginal operative preparation in patients undergoing gynecologic surgery. Am J Infect Control 2016; 44: 996-8.
25. Bratzler DW, Houck PM; Surgical Infection Prevention Guideline Writers Workgroup. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Am J Surg 2005; 189: 395-404.
26. Nelson Richard L, Gladman E, Barbateskovic M. Antimicrobial prophylaxis for colorectal surgery. The Cochrane Database of Systematic Reviews 2014, Issue 5. Art. No.: CD001181. doi: 10. 1002/14651858.CD001181.pub4.
27. van der Slegt J, van der Laan L, Veen EJ, Hendriks Y, Romme J, Kluytmans J. Implementation of a bundle of care to reduce surgical site infections in patients undergoing vascular surgery. PLoS One 2013; 8: e71566.
28. Cima R, Dankbar E, Lovely J, Pendlimari R, Aronhalt K, Nehring S, et al; Colorectal Surgical Site Infection Reduction Team. Colorectal surgery surgical site infection reduction program: a national surgical quality improvement program-driven multidisciplinary single-institution experience. J Am Coll Surg 2013; 216: 23-33.
29. Keenan JE, Speicher PJ, Thacker JK, Walter M, Kuchibhatla M, Mantyh CR. The preventive surgical site infection bundle in colorectal surgery. JAMA Surg 2014; 149: 1045-52.
30. Waits SA, Fritze D, Banerjee M, Zhang W, Kubus J, Englesbe MJ, et al. Developing an argument for bundled interventions to reduce surgical site infection in colorectal surgery. Surgery 2014; 155: 602-6.
31. Johnson MP, Kim SJ, Langstraat CL, Jain S, Habermann EB, Wentink JE, et al. Using bundled interventions to reduce surgical site infection after major gynecologic cancer surgery. Obstet Gynecol 2016; 127: 1135-44.
32. Jung B, Påhlman L, Nyström PO, Nilsson E; Mechanical Bowel Preparation Study Group. Multicentre randomized clinical trial of mechanical bowel preparation in elective colonic resection. Br J Surg 2007; 94: 689-95.
33. Contant CM, Hop WC, van?t Sant HP, Oostvogel HJ, Smeets HJ, Stassen LP, et al. Mechanical bowel preparation for elective colorectal surgery: a multicentre randomised trial. Lancet 2007; 370: 2112-7.
34. Wille-Jørgensen P, Guenaga KF, Matos D, Castro AA. Preoperative mechanical bowel cleansing or not? An updated meta-Analysis. Colorectal Dis 2005; 7: 304-10.
35. Guenaga KF, Matos D, Wille-Jørgensen P. Mechanical bowel preparation for elective colorectal surgery. The Cochrane Database of Systematic Reviews 2009, Issue 1. Art. No.: CD001544. doi: 10.1002/14651858.CD001544.pub3.
36. Zhu QD, Zhang QY, Zeng QQ, Yu ZP, Tao CL, Yang WJ. Efficacy of mechanical bowel preparation with polyethylene glycol in prevention of postoperative complications in elective colorectal surgery: a meta-Analysis. Int J Colorectal Dis 2010; 25: 267-75.
37. Cannon JA, Altom LK, Deierhoi RJ, Morris M, Richman J, Vick CC, et al. Preoperative oral antibiotics reduce surgical site infection following elective colorectal resections. Dis Colon Rectum 2012; 55: 1160-6.
38. Morris MS, Graham LA, Chu DI, Cannon JA, Hawn MT. Oral antibiotic bowel preparation significantly reduces surgical site infection rates and readmission rates in elective colorectal surgery. Ann Surg 2015; 261: 1034-40.
39. Kiran RP, Murray AC, Chiuzan C, Estrada D, Forde K. Combined preoperative mechanical bowel preparation with oral antibiotics significantly reduces surgical site infection, anastomotic leak, and ileus after colorectal surgery. Ann Surg 2015; 262: 416-25; discussion 423-5.
40. Scarborough JE, Mantyh CR, Sun Z, Migaly J. Combined mechanical and oral antibiotic bowel preparation reduces incisional surgical site infection and anastomotic leak rates after elective colorectal resection: an analysis of colectomy-Targeted ACS NSQIP. Ann Surg 2015; 262: 331-7.
41. Dolejs SC, Guzman MJ, Fajardo AD, Robb BW, Holcomb BK, Zarzaur BL, et al. Bowel preparation is associated with reduced morbidity in elderly patients undergoing elective colectomy. J Gastrointest Surg 2017; 21: 372-9.
42. Nelson G, Altman AD, Nick A, Meyer LA, Ramirez PT, Achtari C, et al. Guidelines for pre- And intra-operative care in gynecologic/oncology surgery: enhanced Recovery after Surgery (ERAS) Society recommendations-Part I. Gynecol Oncol 2016; 140: 313-22.
43. Wick EC, Provonost PJ, Fader AN. Trans-surgical disciplines collaboration is an effective strategy for expediting quality improvement. Ann Surg 2016; 264: 915-16.
44. Engelen MJ, Kos HE, Willemse PH, Aalders JG, de Vries EG, Schaapveld M, et al. Surgery by consultant gynecologic oncologists improves survival in patients with ovarian carcinoma. Cancer 2006; 106: 589-98.
45. Bristow RE, Berek JS. Surgery for ovarian cancer: how to improve survival. Lancet 2006; 367: 1558-60.
46. Mu Y, Edwards JR, Horan TC, Berrios-Torres SI, Fridkin SK. Improving risk-Adjusted measures of surgical site infection for the National Healthcare Safety Network. Infect Control Hosp Epidemiol 2011; 32: 970-86.